Tag: Drug compounding

According to the FDA, compounded drugs pose a higher risk than approved drugs because they are not tested for safety or efficacy. This is a crucial consideration when asking, **what is the difference between oral and compounded semaglutide?**

Prescriptions for semaglutide, the active ingredient in Ozempic, surged by 442% between 2021 and 2023 [1.6.1]. This guide addresses the critical question: **Is compounded semaglutide as effective as Ozempic?**

Following widespread tirzepatide shortages that lasted into late 2024, the U.S. Food and Drug Administration (FDA) has ended the temporary period allowing compounding pharmacies to produce versions of the active ingredient in Zepbound. As of early 2025, compounded Zepbound is no longer widely or legally available, and patients who used these versions must transition to FDA-approved alternatives.

According to the FDA, compounded semaglutide products pose a higher risk to patients than FDA-approved drugs because they do not undergo the same stringent safety, quality, or effectiveness review. This makes the crucial question, 'Is compounded semaglutide the same as Ozempic?' essential for consumer safety and informed decision-making.